|
Stephen M. Dow has served as a director of the Company since 1989 and served as Chairperson of the Board of Directors from May 2002 to May 2005. Since 1983 Mr. Dow has served as a general partner of Sevin Rosen Funds a venture capital investment firm. Mr. Dow serves on the Board of Directors of Cytokinetics Inc. a publicly traded biopharmaceutical company.
Mr. Dow is Chairman of the Nominating and Corporate Governance Committee and a member of the Compensation Committee. The Board of Directors has determined that Mr. Dow is independent within the meaning of the Company’s director independence standards and the director independence standards of The Nasdaq Stock Market Inc. (Nasdaq).
Mr. Dow attended the Corporate Governance Program on June 1-4 2004 at Stanford University. Learn more about this program. | 